Renal electrolyte and fluid handling in the rat following chloroquine and/or ethanol administration.
We postulated that chloroquine and/or ethanol affect plasma arginine vasopressin (AVP) concentrations to alter renal function. Therefore, we studied the effects of chloroquine and/or ethanol on plasma AVP concentrations and fluid, urinary Na(+) and K(+) outputs in separate groups of anaesthetized Sprague-Dawley (SD) rats challenged with a continuous jugular infusion of 0.077 M NaCl at 150 microl.min(-1). After a 3-h equilibration period, vehicle, chloroquine (0.06 microg. min(-1)), ethanol (2.4 or 24 microg.min(-1)) or both chloroquine and ethanol were added to the infusate after 1 h (control) for 1 h 20 min (treatment). The animals were switched back to the infusate alone for the final 1 h 40 min recovery periods. Urine flow Na(+) and K(+) excretion rates were determined at 20-min intervals over the subsequent 4-h postequilibration period. Blood was collected from separate groups of animals at the end of treatment period or equivalent time for control animals for measurement of plasma aldosterone and AVP concentrations by radioimmunoassay. Simultaneous chloroquine and ethanol infusion significantly (p < 0.01) increased plasma chloroquine concentrations in an ethanol dose-dependent manner by comparison with animals administered chloroquine alone. Chloroquine infusion alone (0.06 microg.min(-1)) and/or ethanol (2.4 or 24 microg.min(-1)) elevated plasma AVP concentrations from 9.73 +/- 1.64 fmol.l(-1) in control rats to 15.65 +/- 2.49 fmol.l(-1), 17. 39 +/- 4.21 fmol.l(-1), and 33.87 +/- 6.18 fmol.l(-1), respectively. Separate administration of chloroquine or ethanol at low dose rates increased urinary Na(+) excretion rates. We conclude that the impairment of renal electrolyte handling associated with chloroquine administration may be exacerbated by ethanol.
Musabayane
C T
CT
Department of Physiology, University of Zimbabwe, Mount Pleasant, Zimbabwe. Musabayane@mango.apc.org.zw
Cooper
R G
RG
Osim
E
E
Balment
R J
RJ
D000818:Animals; D000962:Antimalarials / Q000494:pharmacology*; D001127:Arginine Vasopressin / Q000097:blood / Q000187:drug effects*; D001794:Blood Pressure / Q000187:drug effects; D002492:Central Nervous System Depressants / Q000494:pharmacology*; D002738:Chloroquine / Q000494:pharmacology*; D000431:Ethanol / Q000494:pharmacology*; D005919:Glomerular Filtration Rate / Q000187:drug effects*; D008297:Male; D011188:Potassium / Q000097:blood / Q000652:urine; D051381:Rats; D017207:Rats, Sprague-Dawley; D012964:Sodium / Q000097:blood / Q000652:urine; D014554:Urination / Q000187:drug effects; D014556:Urine
D000962:Antimalarials; D002492:Central Nervous System Depressants; D001127:Arginine Vasopressin; D000431:Ethanol; D002738:Chloroquine; D012964:Sodium; D011188:Potassium